Loratadine (Synonyms: SCH 29851) |
| Catalog No.GC15252 |
Loratadine is a non- sedating antihistamine that acts as a selective inverse agonist of peripheral histamine H 1 receptors (K i = 35 nM).
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 79794-75-5
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
Loratadine is a non- sedating antihistamine that acts as a selective inverse agonist of peripheral histamine H 1 receptors (K i = 35 nM). It is a second-generation antihistamine that is often used to treat allergy symptoms. It can inhibit immunologic release of inflammatory mediators[1-3].
Loratadine(75 µM loratadine;24 hours) pre-treatment of exponentially growing cells increased radiation-induced cytotoxicity[4]. Loratadine (10 µM) inhibited TRPV2-dependent responses in a primary culture of mouse endometrial stromal cells and attenuated cell proliferation and migration in cell proliferation and wound healing assays[5]. The expression of H1R was dose-responsively induced by Advanced glycation end products (AGEs) in chondrocytes. Treatment with loratadine((25/50 µM; 24 h) mitigated AGEs-induced oxidative stress, as revealed by suppressed production of mitochondrial ROS and the NADPH oxidase subunit NOX4[6].
Loratadine(5,10 mg/kg; p.o.) significantly reduced gastric bleeding in mice. Loratadine suppress inflammation by specifically targeting TAK1 and suppressing consequent AP-1 signaling pathway activation and inflammatory cytokine production[7]. In ICR mice, single oral administration of loratadine at a dose of 5 or 10 mg/kg significantly inhibited the dorsal scratching behavior induced by histamine or an antigen[8].
References:
[1]. AlMasoud N, Bakheit AH, et,al. Loratadine. Profiles Drug Subst Excip Relat Methodol. 2022;47:55-90. doi: 10.1016/bs.podrm.2021.10.002. Epub 2021 Dec 7. PMID: 35396016.
[2]. Kreutner W, Chapman RW, et,al. Antiallergic activity of loratadine, a non-sedating antihistamine. Allergy. 1987 Jan;42(1):57-63. doi: 10.1111/j.1398-9995.1987.tb02188.x. PMID: 2436504.
[3]. Hunto ST, Kim HG, et,al. Loratadine, an antihistamine drug, exhibits anti-inflammatory activity through suppression of the NF-kB pathway. Biochem Pharmacol. 2020 Jul;177:113949. doi: 10.1016/j.bcp.2020.113949. Epub 2020 Apr 3. PMID: 32251678.
[4]. Soule BP, Simone NL, et,al. Loratadine dysregulates cell cycle progression and enhances the effect of radiation in human tumor cell lines. Radiat Oncol. 2010 Feb 3;5:8. doi: 10.1186/1748-717X-5-8. PMID: 20128919; PMCID: PMC2829588.
[5]. Van den Eynde C, Held K, et,al. Loratadine, an antihistaminic drug, suppresses the proliferation of endometrial stromal cells by inhibition of TRPV2. Eur J Pharmacol. 2022 Aug 5;928:175086. doi: 10.1016/j.ejphar.2022.175086. Epub 2022 Jun 14. PMID: 35714693.
[6]. Gao F, Zhang S. Loratadine Alleviates Advanced Glycation End Product-Induced Activation of NLRP3 Inflammasome in Human Chondrocytes. Drug Des Devel Ther. 2020 Jul 21;14:2899-2908. doi: 10.2147/DDDT.S243512. PMID: 32801633; PMCID: PMC7382759.
[7].Jang J, Hunto ST, et,al. Anti-Inflammatory Activities of an Anti-Histamine Drug, Loratadine, by Suppressing TAK1 in AP-1 Pathway. Int J Mol Sci. 2022 Apr 3;23(7):3986. doi: 10.3390/ijms23073986. PMID: 35409346; PMCID: PMC8999734.
[8]. Hossen MA, Fujii Y, et,al. Effect of loratadine on mouse models of atopic dermatitis associated pruritus. Int Immunopharmacol. 2005 Jul;5(7-8):1331-6. doi: 10.1016/j.intimp.2005.02.004. Epub 2005 Mar 9. PMID: 15914337.
Average Rating: 5 (Based on Reviews and 3 reference(s) in Google Scholar.)
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *